|
@@ -72,27 +72,30 @@
|
72
|
72
|
</div>
|
73
|
73
|
<nav class="header__nav">
|
74
|
74
|
<a href="https://event.leecy.org.tw/mrna/#expert" class="header__nav__item header__nav__item-expert" data-anchor="expert">
|
75
|
|
- <p>專家教你認識 mRNA</p>
|
76
|
|
- <div class="header__nav__item__line"></div>
|
77
|
|
- </a>
|
78
|
|
- <a href="https://event.leecy.org.tw/mrna/#understand" class="header__nav__item header__nav__item-understand" data-anchor="understand">
|
79
|
|
- <p>談談mRNA</p>
|
|
75
|
+ <p>mRNA發展室</p>
|
80
|
76
|
<div class="header__nav__item__line"></div>
|
81
|
77
|
</a>
|
82
|
78
|
<a href="https://event.leecy.org.tw/mrna/#research" class="header__nav__item header__nav__item-research" data-anchor="research">
|
83
|
|
- <p>進入mRNA研究室</p>
|
|
79
|
+ <p>mRNA研究室</p>
|
84
|
80
|
<div class="header__nav__item__line"></div>
|
85
|
81
|
</a>
|
86
|
82
|
<a href="https://event.leecy.org.tw/mrna/#qa" class="header__nav__item header__nav__item-qa" data-anchor="qa">
|
87
|
|
- <p>mRNA疫苗常見問題</p>
|
|
83
|
+ <p>mRNA解答室</p>
|
88
|
84
|
<div class="header__nav__item__line"></div>
|
89
|
85
|
</a>
|
90
|
86
|
<a href="https://event.leecy.org.tw/mrna/#moreref" class="header__nav__item header__nav__item-moreref" data-anchor="moreref">
|
91
|
|
- <p>更多參考資訊</p>
|
|
87
|
+ <p>mRNA輔導室</p>
|
|
88
|
+ <div class="header__nav__item__line"></div>
|
|
89
|
+ </a>
|
|
90
|
+ <a href="https://lin.ee/LP8wXFd" target="_blank" class="header__nav__item header__nav__item-line">
|
|
91
|
+ <p>mRNA客服室</p>
|
92
|
92
|
<div class="header__nav__item__line"></div>
|
93
|
93
|
</a>
|
94
|
94
|
</nav>
|
95
|
95
|
</header>
|
|
96
|
+ <a class="goToLine" href="https://lin.ee/LP8wXFd" target="_blank">
|
|
97
|
+ <img src="./images/button-float.png" >
|
|
98
|
+ </a>
|
96
|
99
|
<!-- expert 專家教a你認識 mRNA -->
|
97
|
100
|
<section id="expert" class="section expert">
|
98
|
101
|
<div class="bg expert__bg">
|
|
@@ -143,7 +146,7 @@
|
143
|
146
|
<img src="./images/understand-title-bg.png" alt="">
|
144
|
147
|
</div>
|
145
|
148
|
<div class="subtitle">
|
146
|
|
- <p>談談mRNA</p>
|
|
149
|
+ <p>mRNA發展室</p>
|
147
|
150
|
</div>
|
148
|
151
|
<div class="title">
|
149
|
152
|
<h2>一分鐘認識mRNA</h2>
|
|
@@ -176,7 +179,7 @@
|
176
|
179
|
<img src="./images/history-title-bg.png" alt="">
|
177
|
180
|
</div>
|
178
|
181
|
<div class="subtitle">
|
179
|
|
- <p>談談mRNA</p>
|
|
182
|
+ <p>mRNA發展室</p>
|
180
|
183
|
</div>
|
181
|
184
|
<div class="title">
|
182
|
185
|
<h2>踏上mRNA歷史軌跡</h2>
|
|
@@ -287,7 +290,7 @@
|
287
|
290
|
</picture>
|
288
|
291
|
</div>
|
289
|
292
|
<div class="title">
|
290
|
|
- <h2>進入mRNA 研究室</h2>
|
|
293
|
+ <h2>mRNA研究室</h2>
|
291
|
294
|
</div>
|
292
|
295
|
<div class="subtitle">
|
293
|
296
|
<p>- 點擊下方圖示了解更多 -</p>
|
|
@@ -300,7 +303,7 @@
|
300
|
303
|
</div>
|
301
|
304
|
<div class="research__name">
|
302
|
305
|
<p>
|
303
|
|
- 引以為傲的mRNA疫苗
|
|
306
|
+ 第一課 <span>▶▶</span> mRNA疫苗
|
304
|
307
|
</p>
|
305
|
308
|
</div>
|
306
|
309
|
</div>
|
|
@@ -310,27 +313,27 @@
|
310
|
313
|
</div>
|
311
|
314
|
<div class="research__name">
|
312
|
315
|
<p>
|
313
|
|
- mRNA疫苗的特色
|
|
316
|
+ 第二課 <span>▶▶</span> mRNA疫苗特色
|
314
|
317
|
</p>
|
315
|
318
|
</div>
|
316
|
319
|
</div>
|
317
|
|
- <div class="research__item" data-bs-toggle="modal" data-bs-target="#unlimitModal">
|
|
320
|
+ <div class="research__item" data-bs-toggle="modal" data-bs-target="#showModal">
|
318
|
321
|
<div class="research__pic">
|
319
|
|
- <img src="./images/research-pic-unlimit.png" alt="">
|
|
322
|
+ <img src="./images/research-pic-show.png" alt="">
|
320
|
323
|
</div>
|
321
|
324
|
<div class="research__name">
|
322
|
325
|
<p>
|
323
|
|
- mRNA疫苗的無限可能
|
|
326
|
+ 第三課 <span>▶▶</span> 疫情下的mRNA疫苗
|
324
|
327
|
</p>
|
325
|
328
|
</div>
|
326
|
329
|
</div>
|
327
|
|
- <div class="research__item" data-bs-toggle="modal" data-bs-target="#showModal">
|
|
330
|
+ <div class="research__item" data-bs-toggle="modal" data-bs-target="#unlimitModal">
|
328
|
331
|
<div class="research__pic">
|
329
|
|
- <img src="./images/research-pic-show.png" alt="">
|
|
332
|
+ <img src="./images/research-pic-unlimit.png" alt="">
|
330
|
333
|
</div>
|
331
|
334
|
<div class="research__name">
|
332
|
335
|
<p>
|
333
|
|
- mRNA疫苗如何在疫情大展身手
|
|
336
|
+ 第四課 <span>▶▶</span> mRNA疫苗無限可能
|
334
|
337
|
</p>
|
335
|
338
|
</div>
|
336
|
339
|
</div>
|
|
@@ -340,7 +343,7 @@
|
340
|
343
|
</div>
|
341
|
344
|
<div class="research__name">
|
342
|
345
|
<p>
|
343
|
|
- mRNA小試身手
|
|
346
|
+ mRNA知識檢定
|
344
|
347
|
</p>
|
345
|
348
|
</div>
|
346
|
349
|
</div>
|
|
@@ -362,7 +365,7 @@
|
362
|
365
|
<img src="./images/qa-title-bg.png" alt="">
|
363
|
366
|
</div>
|
364
|
367
|
<div class="title">
|
365
|
|
- <h2>mRNA疫苗常見問題</h2>
|
|
368
|
+ <h2>mRNA解答室</h2>
|
366
|
369
|
</div>
|
367
|
370
|
</div>
|
368
|
371
|
<p class="qa__desc">
|
|
@@ -546,7 +549,7 @@
|
546
|
549
|
<img src="./images/moreref-line.png" alt="">
|
547
|
550
|
</div>
|
548
|
551
|
<div class="moreref__name">
|
549
|
|
- <p>來錄用你的 mRNA 健康管家!</p>
|
|
552
|
+ <p>立即錄用健康管家</p>
|
550
|
553
|
</div>
|
551
|
554
|
</a>
|
552
|
555
|
<a class="moreref__item moreref__item-map" href="https://covid19vaccine.cdc.gov.tw/" target="_blank">
|
|
@@ -554,7 +557,7 @@
|
554
|
557
|
<img src="./images/moreref-map.png" alt="">
|
555
|
558
|
</div>
|
556
|
559
|
<div class="moreref__name">
|
557
|
|
- <p>搜尋醫療院所 請前往疾管署</p>
|
|
560
|
+ <p>搜尋醫療院所</p>
|
558
|
561
|
</div>
|
559
|
562
|
</a>
|
560
|
563
|
</div>
|
|
@@ -567,7 +570,31 @@
|
567
|
570
|
<footer class="footer">
|
568
|
571
|
<h2>參考資料</h2>
|
569
|
572
|
<p>
|
570
|
|
- 〔1〕 Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes. J Control Release (2015) Table 1). 〔2〕 The Tangled History of mRNA Vaccines. Nature (2021) (Page (the beginnings of mRNA], Paragraph 1, Line 5) 〔3〕 The Tangled History of mRNA Vaccines. Nature (2021) (Figure 2) 〔4〕COV-Power of mRNA – Infographic-US- English 〔5〕mRNA主題_黃立民教授_台詞分鏡表/mRNA疫苗作用機轉 〔6〕CanImmunize/mRNA 101/ <a href="https://learn.canimmunize.ca/en/learn-about-immunization/mrna-101" target="_blank">https://learn.canimmunize.ca/en/learn-about-immunization/mrna-101</a> 〔7〕mRNA主題_黃立民教授_台詞分鏡表/mRNA疫苗作用機轉 〔8〕BBC News/Could mRNA make us superman?/<a href="https://www.bbc.com/future/article/20211122-could-mrna-make-us-superhuman" target="_blank">https://www.bbc.com/future/article/20211122-could-mrna-make-us-superhuman</a> 〔9〕BBC News/Could mRNA make us superman?/<a href="https://www.bbc.com/future/article/20211122-could-mrna-make-us-superhuman" target="_blank">https://www.bbc.com/future/article/20211122-could-mrna-make-us-superhuman</a> 〔10〕mRNA主題_黃立民教授_台詞分鏡表/mRNA疫苗的特色 〔11〕mRNA主題_黃立民教授_台詞分鏡表/mRNA疫苗的特色 〔12〕公視新聞網/2023諾貝爾生醫獎 研發mRNA疫苗2科學家獲得 : <a href="https://news.pts.org.tw/article/659906" target="_blank">https://news.pts.org.tw/article/659906</a> 〔13〕 Taiwan CDC/COVID-19疫苗Q&A/5.疫苗安全: <a href="https://www.cdc.gov.tw/Category/QAPage/U6RuirseltWaY9Nd7LuWXA" target="_blank">https://www.cdc.gov.tw/Category/QAPage/U6RuirseltWaY9Nd7LuWXA</a> 〔14〕衛生福利部:<a href="https://covid19.mohw.gov.tw/ch/cp-4822-74703-205.html" target="_blank">https://covid19.mohw.gov.tw/ch/cp-4822-74703-205.html</a> 〔15〕 World Health Organization. COVID-19 advice for the public: getting vaccinated. Updated April 13, 2022. Accessed February 16, 2023. <a href="https://www.who.int/emergencies/diseases/novelcoronavirus-2019/covid-19-vaccines/advice " target="_blank">https://www.who.int/emergencies/diseases/novelcoronavirus-2019/covid-19-vaccines/advice </a> 〔16〕Flacco ME, Acuti Martellucci C,Baccolini V, De Vito C, Renzi E,Villari P and Manzoli L (2022)COVID-19 vaccines reduce the risk of SARS-CoV-2 reinfection and hospitalization: Meta-analysis. Front. Med. 9:1023507.doi: 10.3389/fmed.2022.1023507 〔17〕Moderna HK Campaign landing page / World Health Organization. Side Effects of COVID-19 Vaccines. Updated31 March 2021. Accessed on 14 October 2022. <a href="https://www.who.int/news-room/feature-stories/detail/side-e%1Eects-of-covid-19-vaccines" target="_blank">https://www.who.int/news-room/feature-stories/detail/side-e%1Eects-of-covid-19-vaccines</a> 〔18〕Moderna HK Campaign Landing Page / World Health Organization COVID-19: Vaccines and vaccine safety. Updated 28 June 2023. Accessed on 8 August 2023. <a href="https://www.who.int/news-room/feature-stories/detail/side-e%1Eects-of-covid-19-vaccines" target="_blank">https://www.who.int/news-room/feature-stories/detail/side-e%1Eects-of-covid-19-vaccines</a> 〔19〕Taiwan CDC/COVID-19疫苗Q&A/5.疫苗安全: <a href="https://www.cdc.gov.tw/Category/QAPage/U6RuirseltWaY9Nd7LuWXA" target="_blank">https://www.cdc.gov.tw/Category/QAPage/U6RuirseltWaY9Nd7LuWXA</a> 〔20〕Taiwan CDC/COVID-19疫苗Q&A/8.孕婦及哺乳婦女: <a href="https://www.cdc.gov.tw/Category/QAPage/aVLK2xpg8y3KYmkLK8X6iA" target="_blank">https://www.cdc.gov.tw/Category/QAPage/aVLK2xpg8y3KYmkLK8X6iA</a> 〔21〕台灣感染症醫學會/6個月-5歲之嬰幼兒疫苗接種建議: <a href="https://fightcovid19.com.tw/" target="_blank">https://fightcovid19.com.tw/</a>
|
|
573
|
+ 〔1〕 Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes. J Control Release (2015) Table 1).
|
|
574
|
+ 〔2〕 The Tangled History of mRNA Vaccines. Nature (2021) (Page (the beginnings of mRNA], Paragraph 1, Line 5)
|
|
575
|
+ 〔3〕 The Tangled History of mRNA Vaccines. Nature (2021) (Figure 2)
|
|
576
|
+ 〔4〕COV-Power of mRNA – Infographic-US- English
|
|
577
|
+ 〔5〕mRNA主題_黃立民教授_台詞分鏡表/mRNA疫苗作用機轉
|
|
578
|
+ 〔6〕CanImmunize/mRNA 101/ <a target="_blank" href="https://learn.canimmunize.ca/en/learn-about-immunization/mrna-101">https://learn.canimmunize.ca/en/learn-about-immunization/mrna-101</a>
|
|
579
|
+ 〔7〕mRNA主題_黃立民教授_台詞分鏡表/mRNA疫苗作用機轉
|
|
580
|
+ 〔8〕BBC News/Could mRNA make us superman?/<a target="_blank" href="https://www.bbc.com/future/article/20211122-could-mrna-make-us-superhuman">https://www.bbc.com/future/article/20211122-could-mrna-make-us-superhuman</a>
|
|
581
|
+ 〔9〕BBC News/Could mRNA make us superman?/<a target="_blank" href="https://www.bbc.com/future/article/20211122-could-mrna-make-us-superhuman">https://www.bbc.com/future/article/20211122-could-mrna-make-us-superhuman</a>
|
|
582
|
+ 〔10〕mRNA主題_黃立民教授_台詞分鏡表/mRNA疫苗的特色
|
|
583
|
+ 〔11〕公視新聞網/2023諾貝爾生醫獎 研發mRNA疫苗2科學家獲得 : <a target="_blank" href="https://news.pts.org.tw/article/659906">https://news.pts.org.tw/article/659906</a>
|
|
584
|
+ 〔12〕 Taiwan CDC/COVID-19疫苗Q&A/5.疫苗安全: <a target="_blank" href="https://www.cdc.gov.tw/Category/QAPage/U6RuirseltWaY9Nd7LuWXA">https://www.cdc.gov.tw/Category/QAPage/U6RuirseltWaY9Nd7LuWXA</a>
|
|
585
|
+ 〔13〕mRNA主題_黃立民教授_台詞分鏡表/mRNA疫苗的特色
|
|
586
|
+ 〔14〕衛生福利部:<a target="_blank" href="https://covid19.mohw.gov.tw/ch/cp-4822-74703-205.html">https://covid19.mohw.gov.tw/ch/cp-4822-74703-205.html</a>
|
|
587
|
+ 〔15〕 World Health Organization. COVID-19 advice for the public: getting vaccinated. Updated April 13, 2022. Accessed February 16, 2023. <a target="_blank" href="https://www.who.int/">https://www.who.int/emergencies/diseases/novelcoronavirus-2019/covid-19-vaccines/advice</a>
|
|
588
|
+ 〔16〕Flacco ME, Acuti Martellucci C,Baccolini V, De Vito C, Renzi E,Villari P and Manzoli L (2022)COVID-19 vaccines reduce the risk of SARS-CoV-2 reinfection and hospitalization: Meta-analysis. Front. Med. 9:1023507.doi: 10.3389/fmed.2022.1023507
|
|
589
|
+ 〔17〕Moderna HK Campaign landing page / World Health Organization. Side Effects of COVID-19 Vaccines. Updated31 March 2021. Accessed on 14 October 2022. <a target="_blank" href="https://www.">https://www.who.int/news-room/feature-stories/detail/side-e%1Eects-of-covid-19-vaccines</a>
|
|
590
|
+ 〔18〕Moderna HK Campaign Landing Page / World Health Organization COVID-19: Vaccines and vaccine safety. Updated 28 June 2023. Accessed on 8 August 2023. <a target="_blank" href="https://www.">https://www.who.int/news-room/feature-stories/detail/side-e%1Eects-of-covid-19-vaccines</a>
|
|
591
|
+ 〔19〕Taiwan CDC/COVID-19疫苗Q&A/5.疫苗安全: <a target="_blank" href="https://www.cdc.gov.tw/Category/QAPage/U6RuirseltWaY9Nd7LuWXA">https://www.cdc.gov.tw/Category/QAPage/U6RuirseltWaY9Nd7LuWXA</a>
|
|
592
|
+ 〔20〕Taiwan CDC/COVID-19疫苗Q&A/8.孕婦及哺乳婦女: <a target="_blank" href="https://www.cdc.gov.tw/Category/QAPage/aVLK2xpg8y3KYmkLK8X6iA">https://www.cdc.gov.tw/Category/QAPage/aVLK2xpg8y3KYmkLK8X6iA</a>
|
|
593
|
+ 〔21〕台灣感染症醫學會/6個月-5歲之嬰幼兒疫苗接種建議: <a target="_blank" href="https://fightcovid19.com.tw/">https://fightcovid19.com.tw/</a>
|
|
594
|
+
|
|
595
|
+
|
|
596
|
+
|
|
597
|
+
|
571
|
598
|
</p>
|
572
|
599
|
<!-- <div class="copyright">
|
573
|
600
|
<p>TW-COV-2300085, Oct 2023</p>
|
|
@@ -581,11 +608,17 @@
|
581
|
608
|
<button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button>
|
582
|
609
|
<div class="modal-body">
|
583
|
610
|
<div class="modal__title">
|
584
|
|
- <h2>引以為傲的mRNA疫苗</h4>
|
|
611
|
+ <h2>mRNA疫苗</h4>
|
|
612
|
+ </div>
|
|
613
|
+ <div class="modal__video">
|
|
614
|
+ <iframe width="560" height="315" src="https://www.youtube.com/embed/Ipg40ew_xcU?si=bEl_bqUTGc0-Y4fT" title="YouTube video player" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" allowfullscreen></iframe>
|
585
|
615
|
</div>
|
586
|
616
|
<div class="modal__preface">
|
587
|
617
|
<h3>mRNA疫苗是如何運作的?</h3>
|
588
|
|
- <p>科學家們設計mRNA疫苗,以教導人體的免疫系統對抗感染源。<span>〔4〕</span></p>
|
|
618
|
+ <p>
|
|
619
|
+ 科學家們設計mRNA疫苗,以教導人體的免疫系統對抗感染源。<span>〔4〕</span><br>
|
|
620
|
+ mRNA疫苗藉由提供RNA進入人體內細胞轉譯出病毒蛋白質,來促使免疫系統反應。
|
|
621
|
+ </p>
|
589
|
622
|
</div>
|
590
|
623
|
<div class="modal__list">
|
591
|
624
|
<div class="modal__item">
|
|
@@ -603,7 +636,7 @@
|
603
|
636
|
</div>
|
604
|
637
|
<div class="modal__text">
|
605
|
638
|
<h4>製作mRNA疫苗</h4>
|
606
|
|
- <p>mRNA是脆弱的單鏈結構,所以mRNA疫苗會使用奈米脂質顆粒來包覆,以確保效果可以在人體正確位置發揮。 <span>〔5〕</span></p>
|
|
639
|
+ <p>mRNA是脆弱的單鏈結構,所以mRNA疫苗會使用奈米脂質顆粒(LNP)來包覆,確保效果可以在人體正確位置發揮。 <span>〔5〕</span></p>
|
607
|
640
|
</div>
|
608
|
641
|
</div>
|
609
|
642
|
<div class="modal__item">
|
|
@@ -611,8 +644,8 @@
|
611
|
644
|
<img src="./images/rearch-popup/proud-pic-3.png" alt="">
|
612
|
645
|
</div>
|
613
|
646
|
<div class="modal__text">
|
614
|
|
- <h4>將mRNA輸入體內</h4>
|
615
|
|
- <p>當注射mRNA疫苗後,抗原呈現細胞(antigen-presenting cell, 簡稱APCs)就會吞噬LNP使之崩解,mRNA這時會促使細胞開始產生一系列抗病毒抗體反應。 <span>〔5〕</span></p>
|
|
647
|
+ <h4>mRNA輸入體內</h4>
|
|
648
|
+ <p>注射mRNA疫苗後,抗原呈現細胞(antigen-presenting cell, 簡稱APCs)就會吞噬LNP使之崩解,mRNA這時會促使細胞開始產生抗病毒抗體反應。<span>〔5〕</span></p>
|
616
|
649
|
<div class="modal__additional">
|
617
|
650
|
<div class="modal__additional__icon">
|
618
|
651
|
<img src="./images/rearch-popup/proud-pic-lamp.png" alt="">
|
|
@@ -620,7 +653,7 @@
|
620
|
653
|
<div class="modal__additional__text">
|
621
|
654
|
<p>
|
622
|
655
|
知識補給站<br>
|
623
|
|
- mRNA和包裹它的奈米脂質顆粒(lipid nanoparticles, 簡稱LNP),從疫苗中引入體內後,會在自然狀態下在2天內分解並離開你的身體。 <span>〔6〕</span>
|
|
656
|
+ mRNA和包裹它的奈米脂質顆粒(lipid nanoparticles, 簡稱LNP),從疫苗中引入體內後,會在自然狀態下在3天內分解並離開你的身體。 <span>〔6〕</span>
|
624
|
657
|
</p>
|
625
|
658
|
</div>
|
626
|
659
|
</div>
|
|
@@ -631,8 +664,8 @@
|
631
|
664
|
<img src="./images/rearch-popup/proud-pic-4.png" alt="">
|
632
|
665
|
</div>
|
633
|
666
|
<div class="modal__text">
|
634
|
|
- <h4>產生抗體</h4>
|
635
|
|
- <p>活化T細胞和B細胞的免疫反應,產生大量抗體來中和病毒,防止病毒入侵未受損的細胞,達到快速防禦的效果。<span>〔7〕</span></p>
|
|
667
|
+ <h4>啟動免疫產生抗體</h4>
|
|
668
|
+ <p>活化T細胞和B細胞的免疫反應,產生大量抗體來辨識和中和病毒,防止病毒入侵未受損的細胞,達到快速防禦的效果。<span>〔7〕</span></p>
|
636
|
669
|
</div>
|
637
|
670
|
</div>
|
638
|
671
|
</div>
|
|
@@ -647,12 +680,15 @@
|
647
|
680
|
<button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button>
|
648
|
681
|
<div class="modal-body">
|
649
|
682
|
<div class="modal__title">
|
650
|
|
- <h2>mRNA疫苗的特色</h4>
|
|
683
|
+ <h2>mRNA疫苗特色</h4>
|
|
684
|
+ </div>
|
|
685
|
+ <div class="modal__video">
|
|
686
|
+ <iframe width="560" height="315" src="https://www.youtube.com/embed/Ipg40ew_xcU?si=bEl_bqUTGc0-Y4fT" title="YouTube video player" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" allowfullscreen></iframe>
|
651
|
687
|
</div>
|
652
|
688
|
<div class="modal__principle">
|
653
|
689
|
<div class="modal__principle__item modal__principle__item-blue">
|
654
|
690
|
<div class="modal__principle__title">
|
655
|
|
- <h3>疫苗原理 </h3>
|
|
691
|
+ <h3>常見疫苗原理</h3>
|
656
|
692
|
</div>
|
657
|
693
|
<div class="modal__principle__text modal__principle__text-pc">
|
658
|
694
|
<p>
|
|
@@ -666,25 +702,31 @@
|
666
|
702
|
</div>
|
667
|
703
|
<div class="modal__principle__text modal__principle__text-pc">
|
668
|
704
|
<p>
|
669
|
|
- 不需要注射抗原本身。將抗原的基因序列或「代碼」翻譯成的mRNA,誘導身體產生真實的抗體。然後,mRNA會被人體的自然防禦機制降解而消失,留下抗體對抗病毒。
|
|
705
|
+ 不需要注射抗原本身。將抗原的基因序列或「代碼」翻譯成的mRNA,誘導人體產生真實的抗體。然後,mRNA會被人體的自然防禦機制降解而消失,留下抗體對抗病毒。
|
670
|
706
|
</p>
|
671
|
707
|
</div>
|
672
|
708
|
</div>
|
673
|
709
|
<div class="modal__principle__text modal__principle__text-mb">
|
674
|
710
|
<p>
|
675
|
|
- 不需要注射抗原本身。將抗原的基因序列或「代碼」翻譯成的mRNA,誘導身體產生真實的抗體。然後,mRNA會被人體的自然防禦機制降解而消失,留下抗體對抗病毒。
|
|
711
|
+ 注射被稱為抗原的滅活病毒蛋白質,刺激人體免疫系統識別病毒,當病毒再次出現時快速被消滅或控制。 <span>〔8〕</span>
|
676
|
712
|
</p>
|
677
|
713
|
</div>
|
678
|
714
|
<div class="modal__principle__text modal__principle__text-mb">
|
679
|
715
|
<p>
|
680
|
|
- 不需要注射抗原本身。將抗原的基因序列或「代碼」翻譯成的mRNA,誘導身體產生真實的抗體。然後,mRNA會被人體的自然防禦機制降解而消失,留下抗體對抗病毒。
|
|
716
|
+ 不需要注射抗原本身。將抗原的基因序列或「代碼」翻譯成的mRNA,誘導人體產生真實的抗體。然後,mRNA會被人體的自然防禦機制降解而消失,留下抗體對抗病毒。
|
681
|
717
|
</p>
|
682
|
718
|
</div>
|
683
|
719
|
</div>
|
684
|
720
|
<h3>mRNA疫苗的五大特色</h3>
|
685
|
721
|
<div class="modal__list">
|
686
|
722
|
<div class="modal__item">
|
687
|
|
- <h4>應變性 : </h4>
|
|
723
|
+ <h4>高效性 : </h4>
|
|
724
|
+ <div class="modal__text">
|
|
725
|
+ <p>mRNA疫苗因為開發週期快,在生產過程中也更安全。</p>
|
|
726
|
+ </div>
|
|
727
|
+ </div>
|
|
728
|
+ <div class="modal__item">
|
|
729
|
+ <h4>應變性 : </h4>
|
688
|
730
|
<div class="modal__text">
|
689
|
731
|
<p>mRNA 疫苗可以快速改變抗原設計,隨時製造出需要的新抗原,以快速應對病毒基因的突變。<span>〔9〕</span></p>
|
690
|
732
|
</div>
|
|
@@ -698,7 +740,7 @@
|
698
|
740
|
<div class="modal__item">
|
699
|
741
|
<h4>不滯留性: </h4>
|
700
|
742
|
<div class="modal__text">
|
701
|
|
- <p>不會長期停留體內且無其他毒性風險。 </p>
|
|
743
|
+ <p>不會長期停留體內且無其他毒性風險。</p>
|
702
|
744
|
</div>
|
703
|
745
|
</div>
|
704
|
746
|
<div class="modal__item">
|
|
@@ -707,12 +749,6 @@
|
707
|
749
|
<p>免疫反應更接近自然感染型態,危險性較低。<span>〔10〕</span></p>
|
708
|
750
|
</div>
|
709
|
751
|
</div>
|
710
|
|
- <div class="modal__item">
|
711
|
|
- <h4>高效性 : </h4>
|
712
|
|
- <div class="modal__text">
|
713
|
|
- <p>mRNA疫苗因為開發週期快,在生產過程中也更安全,也無需耗費如傳統疫苗研發時的大量成本。</p>
|
714
|
|
- </div>
|
715
|
|
- </div>
|
716
|
752
|
</div>
|
717
|
753
|
</div>
|
718
|
754
|
</div>
|
|
@@ -725,10 +761,10 @@
|
725
|
761
|
<button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button>
|
726
|
762
|
<div class="modal-body">
|
727
|
763
|
<div class="modal__title">
|
728
|
|
- <h2>mRNA疫苗的無限可能</h4>
|
|
764
|
+ <h2>mRNA疫苗無限可能</h4>
|
729
|
765
|
</div>
|
730
|
766
|
<div class="modal__preface">
|
731
|
|
- <p>針對mRNA疫苗,目前仍需以超低溫條件來儲存和運送。 <span>〔11〕</span></p>
|
|
767
|
+ <p>針對mRNA疫苗,目前仍需以超低溫條件來儲存和運送。<span>〔13〕</span></p>
|
732
|
768
|
</div>
|
733
|
769
|
<div class="modal__preface">
|
734
|
770
|
<h3>mRNA疫苗還有什麼可能性?</h3>
|
|
@@ -795,15 +831,70 @@
|
795
|
831
|
<button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button>
|
796
|
832
|
<div class="modal-body">
|
797
|
833
|
<div class="modal__title">
|
798
|
|
- <h2>mRNA疫苗<br class="d-lg-block">如何在疫情大展身手</h4>
|
|
834
|
+ <h2>疫情下的mRNA疫苗</h4>
|
|
835
|
+ </div>
|
|
836
|
+ <div class="modal__video">
|
|
837
|
+ <iframe width="560" height="315" src="https://www.youtube.com/embed/Ipg40ew_xcU?si=bEl_bqUTGc0-Y4fT" title="YouTube video player" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" allowfullscreen></iframe>
|
799
|
838
|
</div>
|
800
|
839
|
<div class="modal__preface">
|
801
|
840
|
<p>
|
802
|
841
|
2023年諾貝爾生醫獎由匈牙利裔的美籍科學家卡里科(Katalin Kariko),和美國科學家魏斯曼(Drew Weissman)共同獲獎。兩人長期致力於mRNA疫苗研發,因為在核苷(nucleoside)修飾的有關發現,得以促成開發有效的COVID-19信使核糖核酸(mRNA)疫苗,故獲得醫學獎殊榮。<br>
|
803
|
842
|
而藉由他們的突破性發現,人們根本性的改變對於mRNA如何與免疫系統相互作用的理解,在現代人類面臨健康最大威脅之一的COVID-19疫情期間,兩位科學家為空前的疫苗研發速度做出貢獻。
|
804
|
|
- <span>〔12〕</span>
|
|
843
|
+ <span>〔11〕</span>
|
805
|
844
|
</p>
|
806
|
845
|
</div>
|
|
846
|
+ <h3>新冠mRNA 疫苗五大特色:</h3>
|
|
847
|
+ <div class="modal__feature">
|
|
848
|
+ <div class="modal__feature__item">
|
|
849
|
+ <p>
|
|
850
|
+ <span class="red">不使用</span><br>
|
|
851
|
+ 可能引起新冠肺炎<br>
|
|
852
|
+ 的完整病毒
|
|
853
|
+ </p>
|
|
854
|
+ </div>
|
|
855
|
+ <div class="modal__feature__item">
|
|
856
|
+ <p class="d-lg-none">
|
|
857
|
+ 在 mRNA 按指令<br>
|
|
858
|
+ 完成任務後<br>
|
|
859
|
+ 細胞會將其<br>
|
|
860
|
+ <span class="red">很快分解和消除</span>
|
|
861
|
+ </p>
|
|
862
|
+ <p class="d-none d-lg-block">
|
|
863
|
+ 在 mRNA 按<br>
|
|
864
|
+ 指令完成任務後<br>
|
|
865
|
+ 細胞會將其<br>
|
|
866
|
+ <span class="red">很快分解和消除</span>
|
|
867
|
+ </p>
|
|
868
|
+ </div>
|
|
869
|
+ <div class="modal__feature__item">
|
|
870
|
+ <p>
|
|
871
|
+ <span class="red">不影響</span><br>
|
|
872
|
+ 人體 DNA<br>
|
|
873
|
+ 及基因
|
|
874
|
+ </p>
|
|
875
|
+ </div>
|
|
876
|
+ <div class="modal__feature__item">
|
|
877
|
+ <p>
|
|
878
|
+ <span class="red">不會導致</span><br>
|
|
879
|
+ 接種者感染<br>
|
|
880
|
+ 新冠肺炎
|
|
881
|
+ </p>
|
|
882
|
+ </div>
|
|
883
|
+ <div class="modal__feature__item">
|
|
884
|
+ <p class="d-lg-none">
|
|
885
|
+ 與所有其他類型的疫苗<br>
|
|
886
|
+ 一樣在安全及效力方面同樣<br>
|
|
887
|
+ <span class="red">具嚴格法規<br class="d-none d-lg-block">審核標準</span>
|
|
888
|
+ <!-- <span class="num">〔13〕</span> -->
|
|
889
|
+ </p>
|
|
890
|
+ <p class="d-none d-lg-block">
|
|
891
|
+ 與所有其他類型的<br>
|
|
892
|
+ 疫苗一樣在安全<br>
|
|
893
|
+ 及效力方面同樣<br>
|
|
894
|
+ <span class="red">具嚴格法規<br>審核標準</span>
|
|
895
|
+ </p>
|
|
896
|
+ </div>
|
|
897
|
+ </div>
|
807
|
898
|
<h3>新冠mRNA疫苗如何運作? </h3>
|
808
|
899
|
<div class="modal__operation">
|
809
|
900
|
<div class="modal__operation__item">
|
|
@@ -812,7 +903,7 @@
|
812
|
903
|
</div>
|
813
|
904
|
<div class="modal__operation__text">
|
814
|
905
|
<p>
|
815
|
|
- 新冠mRNA疫苗向細胞發出指令,要求製造一段無害的蛋白質,稱為「棘蛋白」,<b>與造成新冠肺炎病毒表面的棘蛋白相似</b>。
|
|
906
|
+ 新冠mRNA疫苗透過人體上臂肌肉注射進入。
|
816
|
907
|
</p>
|
817
|
908
|
</div>
|
818
|
909
|
</div>
|
|
@@ -822,7 +913,7 @@
|
822
|
913
|
</div>
|
823
|
914
|
<div class="modal__operation__text">
|
824
|
915
|
<p>
|
825
|
|
- 新冠mRNA疫苗透過人體上臂肌肉注射進入。
|
|
916
|
+ 新冠mRNA疫苗向細胞發出指令,要求製造一段無害的蛋白質,稱為「棘蛋白」,<b>與造成新冠肺炎病毒表面的棘蛋白相似</b>。
|
826
|
917
|
</p>
|
827
|
918
|
</div>
|
828
|
919
|
</div>
|
|
@@ -832,7 +923,7 @@
|
832
|
923
|
</div>
|
833
|
924
|
<div class="modal__operation__text">
|
834
|
925
|
<p>
|
835
|
|
- 一旦指令(mRNA)進入肌肉細胞,細胞會根據指令製造蛋白質片段,產生這種蛋白質片段後,細胞會分解和消除該指令。
|
|
926
|
+ 產生棘蛋白後,細胞會分解和消除發出指令的mRNA。
|
836
|
927
|
</p>
|
837
|
928
|
</div>
|
838
|
929
|
</div>
|
|
@@ -842,7 +933,7 @@
|
842
|
933
|
</div>
|
843
|
934
|
<div class="modal__operation__text">
|
844
|
935
|
<p>
|
845
|
|
- 該蛋白質片段會出現在細胞表面。當人體免疫系統發現此處不應該有這種蛋白質,會開始啟動免疫反應並分泌抗體。
|
|
936
|
+ 棘蛋白會出現在細胞表面。當人體免疫系統發現此處不應該有這種蛋白質,會開始啟動免疫反應並分泌抗體。
|
846
|
937
|
</p>
|
847
|
938
|
</div>
|
848
|
939
|
</div>
|
|
@@ -852,61 +943,11 @@
|
852
|
943
|
</div>
|
853
|
944
|
<div class="modal__operation__text">
|
854
|
945
|
<p>
|
855
|
|
- 與人體抑制新冠肺炎的自然感染同理。到這個過程結束時,接種者便可獲得免疫保護。<span>〔13〕</span>
|
|
946
|
+ 與人體抑制新冠肺炎的自然感染同理。整個流程結束時,接種者便可獲得免疫保護。<span>〔12〕</span>
|
856
|
947
|
</p>
|
857
|
948
|
</div>
|
858
|
949
|
</div>
|
859
|
950
|
</div>
|
860
|
|
- <h3>新冠mRNA 疫苗五大特色:</h3>
|
861
|
|
- <div class="modal__feature">
|
862
|
|
- <div class="modal__feature__item">
|
863
|
|
- <p>
|
864
|
|
- <span class="red">不使用</span><br>
|
865
|
|
- 引起新冠肺炎<br>
|
866
|
|
- 的活體病毒
|
867
|
|
- </p>
|
868
|
|
- </div>
|
869
|
|
- <div class="modal__feature__item">
|
870
|
|
- <p>
|
871
|
|
- <span class="red">不影響</span><br>
|
872
|
|
- 人體 DNA<br>
|
873
|
|
- 及基因
|
874
|
|
- </p>
|
875
|
|
- </div>
|
876
|
|
- <div class="modal__feature__item">
|
877
|
|
- <p>
|
878
|
|
- <span class="red">不會導致</span><br>
|
879
|
|
- 接種者感染<br>
|
880
|
|
- 新冠肺炎
|
881
|
|
- </p>
|
882
|
|
- </div>
|
883
|
|
- <div class="modal__feature__item">
|
884
|
|
- <p class="d-lg-none">
|
885
|
|
- 在 mRNA 按指令完成<br>
|
886
|
|
- 任務後細胞很快會將其<br>
|
887
|
|
- <span class="red">分解和消除</span>
|
888
|
|
- </p>
|
889
|
|
- <p class="d-none d-lg-block">
|
890
|
|
- 在 mRNA 按<br>
|
891
|
|
- 指令完成任務後<br>
|
892
|
|
- 細胞很快會將其<br>
|
893
|
|
- <span class="red">分解和消除</span>
|
894
|
|
- </p>
|
895
|
|
- </div>
|
896
|
|
- <div class="modal__feature__item">
|
897
|
|
- <p class="d-lg-none">
|
898
|
|
- 與所有其他類型的疫苗<br>
|
899
|
|
- 一樣在安全及效力方面同樣<br>
|
900
|
|
- <span class="red">具嚴格法規<br class="d-none d-lg-block">審核標準</span><span class="num">〔13〕</span>
|
901
|
|
- </p>
|
902
|
|
- <p class="d-none d-lg-block">
|
903
|
|
- 與所有其他類型的<br>
|
904
|
|
- 疫苗一樣在安全<br>
|
905
|
|
- 及效力方面同樣<br>
|
906
|
|
- <span class="red">具嚴格法規<br>審核標準</span>
|
907
|
|
- </p>
|
908
|
|
- </div>
|
909
|
|
- </div>
|
910
|
951
|
</div>
|
911
|
952
|
</div>
|
912
|
953
|
</div>
|
|
@@ -918,7 +959,7 @@
|
918
|
959
|
<button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button>
|
919
|
960
|
<div class="modal-body">
|
920
|
961
|
<div class="modal__title">
|
921
|
|
- <h2>mRNA小試身手</h4>
|
|
962
|
+ <h2>mRNA知識檢定</h4>
|
922
|
963
|
</div>
|
923
|
964
|
<div class="modal__preface">
|
924
|
965
|
<p>你好像更了解mRNA了,來點小試身手吧 !</p>
|